Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bulgarini

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Blood|December 1, 1994
Key functional role and lineage-specific expression of selected HOXB genes in purified hematopoietic progenitor differentiationA Giampaolo, P Sterpetti, D Bulgarini, et al.
Immunology|November 1, 1988
Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6D Habetswallner, E Pelosi, D Bulgarini, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1989
Zinc modulates the mitogenic activation of human peripheral blood lymphocytesD Bulgarini, D Habetswallner, G Boccoli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1991
IL-6/BSF-2 selectively stimulates the GO----S progression of CD8+ lymphocytesD Bulgarini, S Scalzo, G Boccoli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1991
Long-term culture growth of CD4-CD8- lymphocytes exhibiting elevated non-MHC-restricted cytotoxic activityE Montesoro, D Bulgarini, A Carè, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotypeU Testa, A Care, E Montesoro, et al.
The Journal of Experimental Medicine|February 1, 1991
Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastasesV Ciolli, L Gabriele, P Sestili, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endotheliumG Salvo, P Samoggia, R Masciulli, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Interleukin 2 in cancer therapyU Testa, E Montesoro, D Bulgarini, et al.
International Journal of Cancer|December 15, 1989
Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumorsF Belardelli, V Ciolli, U Testa, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood|December 1, 1994
Key functional role and lineage-specific expression of selected HOXB genes in purified hematopoietic progenitor differentiationA Giampaolo, P Sterpetti, D Bulgarini, et al.
Immunology|November 1, 1988
Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6D Habetswallner, E Pelosi, D Bulgarini, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1989
Zinc modulates the mitogenic activation of human peripheral blood lymphocytesD Bulgarini, D Habetswallner, G Boccoli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1991
IL-6/BSF-2 selectively stimulates the GO----S progression of CD8+ lymphocytesD Bulgarini, S Scalzo, G Boccoli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1991
Long-term culture growth of CD4-CD8- lymphocytes exhibiting elevated non-MHC-restricted cytotoxic activityE Montesoro, D Bulgarini, A Carè, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotypeU Testa, A Care, E Montesoro, et al.
The Journal of Experimental Medicine|February 1, 1991
Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastasesV Ciolli, L Gabriele, P Sestili, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endotheliumG Salvo, P Samoggia, R Masciulli, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Interleukin 2 in cancer therapyU Testa, E Montesoro, D Bulgarini, et al.
International Journal of Cancer|December 15, 1989
Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumorsF Belardelli, V Ciolli, U Testa, et al.
Pageof 2